{"date": "2022-01-24 14:54:19.238000+00:00", "ticker": "AMZN", "mrkt_info": {"open": 2890.88, "close": 2777.45}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-body\">\n<pre>ELSE NUTRITION HOLDINGS INC (\"BABY-V;BABYF-0\")\n- Up-Listing to the Toronto Stock Exchange\n\n     Else Nutrition Holdings Inc. (\"Else\" or, the \"Company\") is pleased to\nannounce that it has received final approval for the listing of its common\nshares and warrants on the Toronto Stock Exchange (the \"TSX\").\n\n     The Company's common shares and warrants will commence trading on the\nTSX effective as of market open on Tuesday, January 25, 2022, under the\ncurrent trading symbols of \"BABY\", \"BABY.WT\" and \"BABY.WT.A\". In connection\nwith the TSX listing, the Company's common shares and warrants will be\nconcurrently delisted from the TSX Venture Exchange.\n\n     The TSX is the premier stock exchange for Canadian and international\ncompanies, offering enhanced visibility, liquidity, and access to capital.\nELSE believes that a TSX listing is a logical next step in the Company's\nprogression which should facilitate access to a broader range of investors.\n\n     \"Listing on the TSX is a confirmation of our progress and marks\nanother milestone on our journey, as we take significant strides in\npreparing ELSE for global growth,\" said Hamutal Yitzhak, ELSE co-founder &amp;\nCEO. \"This up-listing will serve to increase the exposure of our story and\nbusiness potential to additional investors in the capital markets community\nand will further support growth of our investor base.\"\n\n     About Else Nutrition Holdings Inc.\n\n     Else Nutrition GH Ltd. is an Israel-based food and nutrition company\nfocused on developing innovative, clean and plant-based food and nutrition\nproducts for infants, toddlers, children, and adults. Its revolutionary,\nplant-based, non-soy, formula is a clean-ingredient alternative to\ndairy-based formula. Else Nutrition (formerly INDI) won the \"2017 Best\nHealth and Diet Solutions\" award at the Global Food Innovation Summit in\nMilan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked\nas the #1 Top seller in the baby and toddler formula category on Amazon.\nThe holding company, Else Nutrition Holdings Inc., is a publicly traded\ncompany, listed as TSX Venture Exchange under the trading symbol BABY and\nis quoted on the US OTC Markets QX board under the trading symbol BABYF and\non the Frankfurt Exchange under the symbol 0YL. Else's Executives include\nleaders hailing from leading infant nutrition companies. Many of Else\nadvisory board members had past executive roles in companies such as Mead\nJohnson, Abbott Nutrition, Plum Organics and leading infant nutrition\nSocieties, and some of them currently serve in different roles in leading\nmedical centers and academic institutes such as Boston Children's Hospital,\nPediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider\nChildren's Medical Center of Israel, Rambam Medical Center and Technion,\nIsrael and University Hospital Brussels, Belgium.\n\n     For more information, visit: elsenutrition.com or @elsenutrition on\nFacebook and Instagram.\n\nContact:Erin Jundef\nBrilliant PR\nerinj@brilliantpr.com\n\nContact:\n\nMrs. Hamutal Yitzhak, CEO, Co-Founder &amp; Director\nELSE Nutrition Holdings Inc.\nE: hamutaly@elsenutrition.com\nP: +972(0)3-6445095\n\nMr. Sokhie Puar, Director of Else Nutrition\nE: sokhiep@elsenutrition.com\nP: 604-603-7787\n\nUS Investor Relations Contact:\n\nLytham Partners, LLC\nMr. Ben Shamsian\nNew York | Phoenix\nE: shamsian@lythampartners.com\nP: 646-829-9701\n\n     TSX Venture Exchange\n\n     Neither the TSX Venture Exchange nor its regulation services provider\n(as that term is defined in the policies of the TSX Venture Exchange)\naccepts responsibility for the adequacy or accuracy of this release.\n\n     Caution Regarding Forward-Looking Statements\n\n     This press release contains statements that may constitute\n\"forward-looking statements\" within the meaning of applicable securities\nlegislation. Forward-looking statements are typically identified by words\nsuch as \"will\", \"expect\" or similar expressions. Forward-looking statements\nin this press release include statements with respect to the anticipated\ndates for filing the Company's financial disclosure documents. Such\nforward-looking statements reflect current estimates, beliefs and\nassumptions, which are based on management's perception of current\nconditions and expected future developments, as well as other factors\nmanagement believes are appropriate in the circumstances. No assurance can\nbe given that the foregoing will prove to be correct. Forward-looking\nstatements made in this press release assume, among others, the expectation\nthat listing on the FSE will create additional liquidity and attract\nadditional investors in the European market. Actual results may differ from\nthe estimates, beliefs and assumptions expressed or implied in the\nforward-looking statements. Readers are cautioned not to place undue\nreliance on any forward-looking statements, which reflect management's\nexpectations only as of the date of this press release. The Company\ndisclaims any obligation to update or revise any forward-looking\nstatements, whether as a result of new information, future events or\notherwise, except as required by law.\n                       ______________________________\n       _______________________________________________\n\n     ____________________________________________________________   \n      (c)2022 Market News Publishing Inc.  All rights reserved.    \n Toronto:(416)366-8881   Vancouver:(604)689-1101   Fax:(604)689-1106\n\n     2202300393.MNPRE2202301221-05571220220124</pre>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2022 Thomson Reuters Limited.</p></div>"}